Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Understand zero based budgeting mistakes that drain funds and implement corrective steps to protect your wallet and grow savings.
23,450 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A new advocacy group backing Kalshi’s prediction market efforts has publicly launched in Washington, with former Whit...
As markets wobble in mid-2026, a trio of NYSE dividend names stands out for safety and income. They combine durable c...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...
Investors eye SpaceX's potential IPO as the space economy broadens; public peers already provide exposure across laun...
Datadog's CEO recently sold a sizable block of shares. This article breaks down the numbers, explains why insiders se...
Salesforce is a powerhouse, but big questions remain about margins and AI-driven pricing. This piece explains why I’m...
Income-focused investors are turning to a small group of high-yield energy names that offer cash-flow visibility and ...
Palantir trades near the $150 level amid volatility. This guide breaks down whether palantir technologies stock no-br...
In May, Redwire surged as investors weighed earnings, AI data-center potential, and a SpaceX IPO rumor mill. This gui...
As the quarterly earnings cycle wraps, universal (uve) 2025 earnings take center stage for growth-focused investors. ...
Copper prices surge to multi-year highs as supply tightness persists. Four copper miners under $30 are showing signs ...